NBY News and Press, NovaBay Pharmaceuticals Inc. From 05/09/22

NovaBay Pharmaceuticals (NYSE:NBY) said it expanded its top-selling Kakadu C and Calm Cool + Corrected product lines by introducing new products with anti-aging ingredients to help reduce the appearance of wrinkles, fine lines, pores and discoloration. "We've expanded two highly popular skinc...

Next generation of popular skincare solutions combine anti-aging and brightening agents to help reduce the appearance of wrinkles, fine lines, pores and discoloration for normal and sensitive skin types NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a ph...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three months ended March 31, 2022 after market close on Thursday, May 12, 2022 and will hold an investment community conference call that day beginning at 4:30 p.m. ...

Calm Cool + Corrected Eczema + Dermatitis Clinical Repair Balm to be Featured on “Get Ready, Gorgeous with Ali” on April 12 at 8 a.m. Eastern Time NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a company developing and commercializing high-...

Soap-free and pH-balanced formula features jojoba seed and orange peel oils to gently lift away impurities and remove makeup without drying skin NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company developing and commercializing high-q...

NovaBay Pharma (NBY -2.2%) posted lower-than-expected Q4 revenue Net product revenue for the quarter rose 40% to $2.6 million, but missed estimates by $0.71M. The company recorded $1.6M from Avenova spray sales, $0.6M of DERMAdoctor product sales. The company's operating costs were ...

NovaBay Pharmaceuticals, Inc. (NBY) Q4 2021 Earnings Conference Call March 29, 2022 16:30 ET Company Participants Jody Cain - Investor Relations Justin Hall - Chief Executive Officer and General Counsel Andy Jones - Chief Financial Officer Conference Call Participants Destiny Hance - Ladenbur...

NovaBay press release (NYSE:NBY): Q4 GAAP EPS of -$0.02 beats by $0.03. Revenue of $2.64M (+39.7% Y/Y) misses by $0.71M. Shares +1.56%. For further details see: NovaBay GAAP EPS of -$0.02 beats by $0.03, revenue of $2.64M misses by $0.71M

Fourth quarter net product revenue increased 40% on record Avenova spray unit sales 2021 Avenova spray net revenue increased 15% on 31% growth in unit sales 2020 net product revenue boosted by $3.1 million in non-recurring PPE product sales Company executing ...

AMPE, AREC, CALM, CHWY, CRMD, CWBR, CWCO, HTGM, INFI, OTCQB:LQMT, LULU, MLKN, MOTS, MU, MVST, NBRV, NBY, OTC:OIBZQ, OPGN, PAVM, PRGS, PVH, RH, SNDL, SPWH, SUNL, VRNT, ZVO For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Tuesd...